Position in GILD
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$10,589,890
+$957,992 QoQ
Shares Held
75,984
-3.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $104,513,791 across 18 Drug Manufacturers - General names. GILD ranks #4 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,405 | $27,965,606 | |
| 2 | ABBV |
AbbVie Inc.
|
103,875 | $22,591,773 | |
| 3 | JNJ |
Johnson & Johnson
|
80,406 | $19,654,442 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
75,984 | $10,589,890 | |
| 5 | MRK |
Merck & Co., Inc.
|
56,169 | $6,756,569 | |
| 6 | PFE |
Pfizer Inc
|
129,199 | $3,627,907 | |
| 7 | AMGN |
Amgen Inc
|
10,183 | $3,582,888 | |
| 8 | NVS |
Novartis AG
|
16,366 | $2,499,906 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,589,890 | 75,984 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $9,631,898 | 78,474 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $8,266,170 | 74,470 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,906,060 | 35,231 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $3,828,076 | 34,164 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $3,421,384 | 37,040 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,294,744 | 39,298 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,987,819 | 58,123 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,352,945 | 45,774 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,510,649 | 43,336 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,232,087 | 43,129 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $3,433,468 | 44,550 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $3,662,793 | 44,146 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $3,626,132 | 42,238 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $2,753,039 | 44,627 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,283,694 | 36,947 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,108,037 | 35,459 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $2,414,572 | 33,254 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $2,165,280 | 30,999 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $2,020,490 | 29,342 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,745,462 | 27,007 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,525,596 | 26,186 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,683,128 | 26,636 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $2,187,942 | 28,437 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $2,098,812 | 28,074 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||